Related Experiment Video
Updated: Jun 27, 2025

07:59
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.1K
Individualized radiology screening for newly diagnosed nasopharyngeal carcinoma
Yiying Xu1, Ting Xu1, Qiwei Yao1
1Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, People's Republic of China.
Oral Oncology
|May 7, 2024
Summary
This study developed a new model to personalize PET/CT screening for nasopharyngeal carcinoma (NPC) patients, identifying those most at risk for distant metastasis to improve staging accuracy.
Area of Science:
- Oncology
- Radiology
- Biomarkers
Background:
- Current nasopharyngeal carcinoma (NPC) staging relies on universal PET/CT screening, despite a low incidence of synchronous distant metastasis (SDM).
- This approach may lead to unnecessary screening in low-risk patients.
Purpose of the Study:
- To develop individualized screening recommendations for NPC patients based on their specific risk of SDM.
- To create a predictive model for identifying patients who would benefit most from PET/CT staging.
Main Methods:
- Retrospective analysis of 18 pre-treatment peripheral blood indicators in 2271 NPC patients.
- Construction of a peripheral blood risk score (PBRS) using LASSO regression.
- Development and validation of a PBRS-based distant metastases (PBDM) model using logistic regression and ROC analysis.
Main Results:
- Key indicators for SDM included Epstein-Barr viral DNA, lymphocyte percentage, lactate dehydrogenase, and monocyte-to-lymphocyte ratio.
- The PBDM model incorporated sex, T stage, N stage, and PBRS, demonstrating good predictive performance.
- Patients were stratified into low-, medium-, and high-risk groups for SDM.
Conclusions:
- The PBDM model provides a personalized approach to PET/CT screening for NPC staging.
- This targeted strategy allows for more efficient use of resources by focusing on patients with a higher risk of SDM.

